À propos
Actions
Données et outils
Évenements
Actualités
WFH statement - EN

Communiqué de la FMH sur la crise israélo-palestinienne

La FMH tient à exprimer toute sa solidarité avec les communautés des troubles de la coagulation en Israël et en Palestine, et avec toutes les personnes actuellement affectées par la crise israélo-palestinienne.

Aussi disponible en : English Español

Les communautés palestinienne et israélienne des troubles de la coagulation connaissent actuellement des difficultés sans précédent. La FMH effectue un suivi et une évaluation attentive de la situation afin de déterminer comment soutenir au mieux les populations touchées.

Une fois que nous aurons établi qu’il est possible d’apporter notre aide de manière efficace et en toute sécurité, nous agirons très rapidement. Nous travaillerons avec nos organisations nationales membres, les prestataires de santé et d’autres acteurs des deux communautés afin que l’aide soit acheminée vers les zones où elle est la plus nécessaire. L’équipe d’aide humanitaire de la FMH se tient prête à livrer les produits dès que les circuits de distribution seront ouverts.

La FMH continuera à communiquer régulièrement des informations sur les activités menées en soutien aux communautés des troubles de la coagulation touchées par la crise. Toute la FMH et ses équipes souhaitent le retour de la sécurité et de la paix pour les deux communautés.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.